IX生物制药有限公司宣布启动定向增发计划，拟募集资金总额不低于600万新元。公司已正式签署配售协议，标志着此次融资活动进入实质性推进阶段。本次募资将用于支持公司核心业务发展及管线药物研发，进一步巩固其在生物医药领域的战略布局。
IX生物制药有限公司宣布启动定向增发计划，拟募集资金总额不低于600万新元。公司已正式签署配售协议，标志着此次融资活动进入实质性推进阶段。本次募资将用于支持公司核心业务发展及管线药物研发，进一步巩固其在生物医药领域的战略布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.